Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Replacement: Director's Dealing

16 Sep 2022 17:21

RNS Number : 8280Z
Asimilar Group PLC
16 September 2022
Β 

The Company's announcement (RNS Number: 3564Z) of 14 September 2022 misstated Mark Horrocks & Family Interests as 6,486,280. This should have stated 6,506,280.

The full amended text is shown below. All other details remain unchanged.

Β 

The information contained in this announcement is deemed by the Company to constitute inside information as stipulated under the EU Market Abuse Regulation (596/2014). Upon publication of the announcement via a regulatory information service, this information is considered to be in the public domain.

14 September 2022

Β 

Β 

ASIMILAR GROUP PLC ('ASIMILAR' OR 'THE COMPANY')

Β 

Director's Dealing

Β 

Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), hereby announces that it was informed on 13 September 2022 that Dewscope Limited, in which Mark Horrocks (Non-Executive Director of the Company) has a 49% interest, purchased 750,000 Asimilar ordinary shares at a price of 4.1p per share on 9 September 2022.

Β 

Following the acquisition, Mr Horrocks's interest in the Company, including the shares held by his mother, Mrs DJ Horrocks, and Dewscope Limited, (in future to be referred to as "Mark Horrocks & Family Interests") is 6,506,280 ordinary shares, representing 5.27% of Asimilar's issued share capital.

Β 

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mark Horrocks

2

Reason for the notification

a)

Position/status

Non-executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Asimilar Group Plc

b)

LEI

213800AYJZ2B8QNY7H15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Ordinary shares of 0.01 pence per share par valueΒ 

Β 

GB00BFX2VL54

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

4.1p

750,000

d)

Aggregated information

-

Aggregated volume

-

Price

Β 

As above

As above

e)

Date of the transaction

9 September 2022

f)

Place of the transaction

London Stock Exchange, AIM

Β 

Β 

-Ends-

Contacts

Asimilar Group plc

John Taylor, Non-Executive Chairman

via Buchanan

Cairn Financial Advisers LLP

Sandy Jamieson / Liam Murray

Tel: +44 20 7213 0880

Peterhouse Capital Limited

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

Buchanan Communications Limited

Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHLFMFTMTBBBRT
Date   Source Headline
18th Nov 20057:01 amRNSPositive Product Test Results
20th Oct 20057:00 amRNSTrading Statement
1st Aug 20059:27 amRNSBoard Appointment
29th Jul 20057:01 amRNSEgypt contract gain
8th Jul 200512:14 pmRNSResult of EGM
29th Jun 20055:30 pmRNSInterim Results
21st Jun 20057:00 amRNSOverseas Contract Gains
15th Jun 20054:03 pmRNSNotice of EGM
15th Jun 20052:21 pmRNSBoard Appointment
10th Jun 20057:00 amRNSOverseas Contract Gains
2nd Jun 20057:01 amRNSUS Collaboration deal
25th May 200512:30 pmRNSIssue of Equity
29th Mar 20051:13 pmRNSAGM Statement
2nd Feb 20054:51 pmRNSFinal Results Replacement
14th Jan 20051:39 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.